Showing results (3071-3080 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|October 8, 2008
Synthesis and in vitro cytotoxic evaluation of novel diazaspiro bicyclo hydantoin derivatives in human leukemia cells: a SAR studyC S Ananda Kumar, C V Kavitha, K Vinaya, et al.
Investigational New Drugs|October 10, 2008
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancerC D Blanke, T M Beer, K Todd, et al.
Investigational New Drugs|July 9, 2008
Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure-activity relationship studyC S Ananda Kumar, S B Benaka Prasad, K Vinaya, et al.
Investigational New Drugs|February 25, 2009
Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumorsTeresa G Hayes, Gerald S Falchook, Atul Varadhachary
Investigational New Drugs|March 21, 2009
Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1,2-dimethyl hydrazine induced rat colon carcinogenesisJebakkan Senapathy Giftson, Sathiavelu Jayanthi, Namasivayam Nalini
Investigational New Drugs|March 24, 2009
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)Robert T O'Donnell, Shiloh M Martin, Yunpeng Ma, et al.
Investigational New Drugs|January 10, 2009
"Classical 3 + 3 design" versus "accelerated titration designs": analysis of 270 phase 1 trials investigating anti-cancer agentsNicolas Penel, Nicolas Isambert, Pierre Leblond, et al.
Investigational New Drugs|May 16, 2009
Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancerSung Yong Oh, Hyun Jin Kim, Tae Hyo Kim, et al.
Investigational New Drugs|June 27, 2009
Anti-tumor effects of nitrosylcobalamin against spontaneous tumors in dogsJoseph A Bauer, Gerald Frye, Anne Bahr, et al.
Investigational New Drugs|August 26, 2009
Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanesDaniel Chan, Wee-Lee Yeo, Maricel Tiemsim Cordero, et al.
Pageof 372